Pacira BioSciences Inc (PCRX)
26.35
+0.85
(+3.33%)
USD |
NASDAQ |
Apr 26, 16:00
26.35
0.00 (0.00%)
After-Hours: 20:00
Pacira BioSciences Total Long Term Debt (Quarterly): 522.44M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 522.44M |
| September 30, 2023 | 524.58M |
| June 30, 2023 | 551.69M |
| March 31, 2023 | 553.77M |
| December 31, 2022 | 689.47M |
| September 30, 2022 | 747.87M |
| June 30, 2022 | 755.65M |
| March 31, 2022 | 923.42M |
| December 31, 2021 | 1.049B |
| September 30, 2021 | 481.90M |
| June 30, 2021 | 475.39M |
| March 31, 2021 | 468.98M |
| December 31, 2020 | 462.68M |
| September 30, 2020 | 456.46M |
| June 30, 2020 | 314.18M |
| March 31, 2020 | 310.08M |
| December 31, 2019 | 306.04M |
| September 30, 2019 | 302.08M |
| June 30, 2019 | 298.18M |
| March 31, 2019 | 294.36M |
| December 31, 2018 | 290.93M |
| September 30, 2018 | 287.23M |
| June 30, 2018 | 283.59M |
| March 31, 2018 | 280.01M |
| December 31, 2017 | 276.50M |
| Date | Value |
|---|---|
| September 30, 2017 | 273.04M |
| June 30, 2017 | 269.65M |
| March 31, 2017 | 266.75M |
| December 31, 2016 | 108.74M |
| September 30, 2016 | 107.56M |
| June 30, 2016 | 106.39M |
| March 31, 2016 | 105.22M |
| December 31, 2015 | 104.04M |
| September 30, 2015 | 104.91M |
| June 30, 2015 | 103.88M |
| March 31, 2015 | 104.14M |
| December 31, 2014 | 103.10M |
| September 30, 2014 | 102.06M |
| June 30, 2014 | 101.03M |
| March 31, 2014 | 100.00M |
| December 31, 2013 | 98.96M |
| September 30, 2013 | 97.93M |
| June 30, 2013 | 96.89M |
| March 31, 2013 | 95.86M |
| December 31, 2012 | 25.19M |
| September 30, 2012 | 24.93M |
| June 30, 2012 | 24.67M |
| March 31, 2012 | 25.00M |
| December 31, 2011 | 25.58M |
| September 30, 2011 | 25.47M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
298.18M
Minimum
Jun 2019
1.049B
Maximum
Dec 2021
536.53M
Average
481.90M
Median
Sep 2021
Total Long Term Debt (Quarterly) Benchmarks
| Dynavax Technologies Corp | 222.70M |
| Arbutus Biopharma Corp | 0.00 |
| Chimerix Inc | 0.125M |
| Karyopharm Therapeutics Inc | 170.92M |
| FibroGen Inc | 71.93M |